(Total Views: 514)
Posted On: 01/04/2020 3:31:49 PM
Post# of 155033
Trading super helpful especially the third link which describes:
“That is why it is important to be ccr5/ccl5 pathway and not possibly through other receptors”
Are the Pharma companies who could be told this too proud to buy Cytodyn or is the asking price to high.
Seems like it would be the easiest business development job in the world especially when Pestell was on board to sell the company - unless price was the sticking point or there is another problem. More human cancer results should minimize the other problem concern.
I suppose we could look back at Humira and hopefully see the same situation at the same stage - inefficient markets at work.
IMO
Read More: https://investorshangout.com/post/view?id=560...z6A5yNf38v
“That is why it is important to be ccr5/ccl5 pathway and not possibly through other receptors”
Are the Pharma companies who could be told this too proud to buy Cytodyn or is the asking price to high.
Seems like it would be the easiest business development job in the world especially when Pestell was on board to sell the company - unless price was the sticking point or there is another problem. More human cancer results should minimize the other problem concern.
I suppose we could look back at Humira and hopefully see the same situation at the same stage - inefficient markets at work.
IMO
Read More: https://investorshangout.com/post/view?id=560...z6A5yNf38v
(0)
(0)
